NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

ALPA LABORATORIES

BSE: 532878 22 Feb 2025
Healthcare
₹ 110.0
Alpa Laboratories Limited specializes in Pharmaceuticals within the Healthcare sector.

ALPA LABORATORIES - Share Price & Details

Market Cap
₹232.0
High /Low
145.0 / 69.9
Stock P/E
9.18
Book Value
₹78.2
Dividend Yield
0.0
ROCE
14.7
ROE
₹12.0
Face Value
10.0
PEG Ratio
0.11
EVEBITDA
₹7.1
Debt
2.26
CMP / FCF
54.2
Debt to equity
₹0.01
NP Ann
16.8
High price all time
145.0
Piotroski score
₹5.0
Graham Number
145.0
No. Eq. Shares
2.1
Net CF
₹-7.10
Net profit
25.2
Price to book value
1.41
Interest Coverage
₹64.2
Low price all time
5.5
Industry PE
35.4
Reserves
₹144
Free Cash Flow
₹-2.74

Price Chart


Volume Chart


Peer Comparison

Stock Net Sales EPS P/E
Shyama Computronics and Servic0.61NA30.9
Triochem Products Ltd.,NA3.60
ALPA LABORATORIES LTD.261.504.239.18
PANCHSHEEL ORGANICS LTD.262.442.7915.9
ONE GLOBAL SERVICE PROVIDER LI333.734.8918.4

Peer Comparison Chart


About ALPA LABORATORIES

Alpa Laboratories Limited, with Security Code 532878, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Alpa Laboratories Limited (NSE:ALPA) Looks Inexpensive But Perhaps Not Attractive Enough

(02 Jan 2025)
With a price-to-earnings (or "P/E") ratio of 12.8x Alpa Laboratories Limited ( NSE:ALPA ) may be sending very bullish...
Read more →

Counterfeit drugs seized after firm sources it from another, labels it as own before export

(28 Nov 2024)
A large stock of counterfeit antibiotics worth Rs 1.33 crore was seized from Jodas Expoim Private Limited in Hyderabad, which sourced the...
Read more →

Alpa Labs Consolidated September 2024 Net Sales at Rs 24.94 crore, down 23.02% Y-o-Y

(28 Nov 2024)
Quarterly Net Profit at Rs. 7.69 crore in September 2024 up 32.77% from Rs. 5.79 crore in September 2023. EBITDA stands at Rs. 10.23 crore...
Read more →

Raid: Telangana DCA seizes huge stock of antibiotics worth Rs1.33 crores

(28 Nov 2024)
Telangana: Drugs Control Administration, Telangana, seized a huge stock of antibiotics worth Rs. 1.33 Crores from the manufacturing facility...
Read more →

DCA seizes antibiotics worth Rs 1.33 cr during raid in Telangana

(28 Nov 2024)
Uniindia: Hyderabad, Nov 27 (UNI) The Drugs Control Administration (DCA) of Telangana seized antibiotics worth Rs 1.33 crore during a raid...
Read more →

Spurious antibiotics worth Rs 1.33 crore seized from a pharmaceutical company in Telangana

(27 Nov 2024)
Telangana drug authorities seized ₹1.33 crore worth of antibiotics from a Siddipet facility on Wednesday. The facility was illegally...
Read more →